Jan 18, 2022 03:49 PM (GMT+8) · EqualOcean
Financial Associated Press, January 18 (Xinhua) - Cylon pharmaceutical announced that its wholly-owned subsidiary parecoxib sodium for injection obtained the notice of approval for supplementary drug application. The main indication of parecoxib sodium for injection is the short-term treatment of postoperative pain.